Carregant...
A method to reduce variability in scoring anti-body mediated rejection in renal allografts: Implications for clinical trials.
Poor reproducibility in scoring antibody mediated rejection (ABMR) using the Banff criteria might limit the use of histology in clinical trials. We evaluated the reproducibility of Banff scoring of 67 biopsies by 6 renal pathologists at 3 institutions. Agreement by any two pathologists was poor: 44....
Guardat en:
| Publicat a: | Transpl Int |
|---|---|
| Autors principals: | , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6328317/ https://ncbi.nlm.nih.gov/pubmed/30179275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tri.13340 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|